Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-142105
Filing Date
2026-04-03
Accepted
2026-04-03 16:05:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 aard_424b5_march_2026.htm 424B5 224133
2 GRAPHIC img231711169_0.jpg GRAPHIC 27677
3 GRAPHIC img231711169_1.gif GRAPHIC 429930
4 GRAPHIC img231711169_2.jpg GRAPHIC 27677
  Complete submission text file 0001193125-26-142105.txt   894083
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-294537 | Film No.: 26838089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)